Phibro Animal Health SA, a leading player in the animal health industry, is headquartered in Belgium and operates extensively across Europe, North America, and Latin America. Founded in 1946, the company has established itself as a trusted provider of innovative solutions for livestock and aquaculture, focusing on health and nutrition.
Phibro's core offerings include vaccines, nutritional products, and pharmaceuticals, all designed to enhance animal well-being and productivity. What sets Phibro apart is its commitment to research and development, ensuring that its products meet the evolving needs of the industry. With a strong market position, Phibro Animal Health SA has achieved notable milestones, including significant advancements in animal health technologies, solidifying its reputation as a reliable partner for farmers and veterinarians alike.
+68 vs industry average
Phibro Animal Health SA’s score of 97 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Phibro Animal Health SA?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Chemicals is among the most carbon-intensive industries
Industry performance
The Chemicals industry has reduced its overall emissions by 6% since 2019
Reported emissions
No reported emissions data is available for Phibro Animal Health SA yet.
Phibro Animal Health SA's reported carbon emissions
Phibro Animal Health SA, headquartered in Belgium, currently does not have specific carbon emissions data available for the most recent year. The company is part of a corporate family that includes GSK plc, from which it inherits various climate initiatives and commitments.
Phibro's climate commitments are influenced by GSK plc's sustainability strategies, which include participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to establish science-based targets for reducing greenhouse gas emissions across their operations. However, specific reduction targets or achievements for Phibro Animal Health SA have not been disclosed.
As a merged entity, Phibro aligns its climate strategies with those of GSK plc, which is actively working towards reducing its carbon footprint and enhancing sustainability practices. The absence of direct emissions data highlights the need for ongoing transparency and commitment to climate action within the industry.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Phibro Animal Health SA’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Phibro Animal Health SA yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from GSK plc
Carbon Disclosure Project
Inherited from GSK plcThe Climate Pledge
Inherited from GSK plcUN Global Compact Climate Champions initiative
Inherited from GSK plcRE 100
Inherited from GSK plcClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Phibro Animal Health SA yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project